Sign in

CIK 0000949858

  • Non-accelerated filer
  • Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954343413
Phone
+1 425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
  5. 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
  7. 4 Open-market sale EVP, CMO sold 3,254 shares at $0.83 ($2,701)
  8. 4 Open-market sale CFO sold 834 shares at $0.83 ($692)
  9. 4 Open-market sale President and CEO sold 12,033 shares at $0.83 ($9,987)
  10. 4 Exercise or conversion Director acquired 5,359 shares (option exercise)
  11. 4 Open-market sale CFO sold 1,427 shares at $2.76 ($3,939)
  12. 4 Open-market sale EVP, CMO sold 1,408 shares at $2.69 ($3,788)
  13. 4 Open-market sale President and CEO sold 4,571 shares at $2.69 ($12,296)
  14. 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
  15. 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
  16. 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
  17. 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
  18. 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
  19. 4 Open-market sale EVP, CMO sold 2,092 shares at $1.88 ($3,933)
  20. 4 Open-market sale President and CEO sold 7,543 shares at $1.88 ($14,181)

Page 13 of 24 · 465 filings